Graphical analysis of 6-fluoro-L-dopa trapping: effect of inhibition of catechol-O-methyltransferase

Details

Serval ID
serval:BIB_43930F2667A1
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Graphical analysis of 6-fluoro-L-dopa trapping: effect of inhibition of catechol-O-methyltransferase
Journal
Journal of Nuclear Medicine
Author(s)
Holden  J. E., Doudet  D., Endres  C. J., Chan  G. L., Morrison  K. S., Vingerhoets  F. J., Snow  B. J., Pate  B. D., Sossi  V., Buckley  K. R., Ruth  T. J.
ISSN
0161-5505 (Print)
Publication state
Published
Issued date
10/1997
Volume
38
Number
10
Pages
1568-74
Notes
Journal Article
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S. --- Old month value: Oct
Abstract
Graphical methods to analyze tracer time-course data allow reliable quantitation of the rate of incorporation of tracer from plasma into a "trapped" kinetic component, even when the details of the kinetic model are unknown. Applications of the method over long time periods often expose the slow reversibility of the trapping process. In the extended graphical method, both trapping rate and a presumed first-order loss rate constant are estimated simultaneously from the time-course data. METHODS: We applied the extended graphical method to 6-fluoro-L-dopa (6-FD), simultaneously estimating the rate of uptake (Ki) and the rate constant for loss from the trapped component (K(loss)) in a single fitting procedure. We applied this approach to study the effects of two catechol-O-methyl-transferase inhibitors on the kinetics of 6-FD in cynomolgus monkeys. RESULTS: Inhibition of peripheral O-methylation with either inhibitor, confirmed by high-performance liquid chromatography analysis of labeled compounds in arterial plasma, had no significant effect on Ki, in agreement with previously reported studies. In contrast, tolcapone, a catechol-O-methyl-transferase inhibitor, having central effects in addition to peripheral effects at the dosage used, decreased K(loss) by 40% from control values (p < 0.002), whereas nitecapone, which has no known central activity, had no significant effect. CONCLUSION: This method provides insight into the neurochemical basis for the kinetic behavior of 6-FD in both health and disease and may be used to define the action of centrally active drugs that influence the metabolism of dopamine.
Keywords
Animals Benzophenones/pharmacology Brain/metabolism/radionuclide imaging Catechol O-Methyltransferase/*antagonists & inhibitors/physiology Catechols/pharmacology Chromatography, High Pressure Liquid Dihydroxyphenylalanine/*analogs & derivatives/diagnostic use/pharmacokinetics Enzyme Inhibitors/pharmacology Fluorine Radioisotopes/*diagnostic use Macaca fascicularis Male Nitrophenols Pentanones/pharmacology *Tomography, Emission-Computed
Pubmed
Web of science
Create date
25/01/2008 13:49
Last modification date
20/08/2019 14:47
Usage data